CLNN
Clene (CLNN)
$28
About Clene (CLNN)
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Details
Daily high
$7.46
Daily low
$6.96
Price at open
$7.46
52 Week High
$13.50
52 Week Low
$2.28
Market cap
85.7M
Dividend yield
0.00%
Volume
184,282
Avg. volume
1.3M
P/E ratio
-2.80
Clene News
Details
Daily high
$7.46
Daily low
$6.96
Price at open
$7.46
52 Week High
$13.50
52 Week Low
$2.28
Market cap
85.7M
Dividend yield
0.00%
Volume
184,282
Avg. volume
1.3M
P/E ratio
-2.80